E116: A New Paradigm for PMR

Update: 2024-11-11

Description

Reading one of my recent newsletters this week, this one about PMR tapers. Be sure to subscribe at ebrheum.com if you want access to the visuals and upcoming editions!

Comments

In Channel

E129: Long Term Routine Laboratory Monitoring in RA

2025-12-0415:17

E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)

2025-11-1219:03

E127: TNFs and All That CHF

2025-09-2221:46

E126: Risk Signals, JAKs, and SELECTIVE-ity

2025-09-0814:34

E125: Adrenal Insufficiency after Stopping Prednisone

2025-06-2917:52

e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study

2025-06-1214:18

E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA

2025-04-3018:13

E122: Guidelines for Maybe Diagnosing HLH

2025-04-1711:18

E121: Obinutuzumab in SLE-LN

2025-04-0218:14

E120: Real Life Use of PEXIVAS-Low

2025-03-0624:33

E119: Teclistamab for Rheumatology Writ Large

2025-02-1010:52

E118: The emerging risk of overdiagnosis in RA and PMR

2025-01-3116:02

E117: Inebilizumab for IgG4-RD (MITIGATE)

2024-12-0312:55

E116: A New Paradigm for PMR

2024-11-1109:29

E115: Benralizumab for EGPA - the MANDARA Study

2024-10-2809:52

E114: Target Trials and STAR-RA with Rishi Desai

2024-10-1431:15

E113: CAR-T is Coming to Rheumatology

2024-09-3014:04

E112: Gabapentin is Trash

2024-09-1206:07

E111: PEXIVAS Subsets with Mike Walsh & Mats Junek

2024-03-2539:27

E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson

2024-03-1424:19

00:00

E116: A New Paradigm for PMR

#box-pro-ellipsis-176536708638118{-webkit-line-clamp:2;}E116: A New Paradigm for PMR

E116: A New Paradigm for PMR

Michael Putman

E116: A New Paradigm for PMR